Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Moodys
Cipla
McKesson
Daiichi Sankyo
Fuji
Baxter
US Army
Fish and Richardson

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018862

« Back to Dashboard

NDA 018862 describes BETATREX, which is a drug marketed by Savage Labs and is included in three NDAs. Additional details are available on the BETATREX profile page.

The generic ingredient in BETATREX is betamethasone valerate. There are sixty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Summary for 018862
Tradename:BETATREX
Applicant:Savage Labs
Ingredient:betamethasone valerate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018862

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;TOPICALStrengthEQ 0.1% BASE
Approval Date:Aug 31, 1983TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Cerilliant
Johnson and Johnson
Accenture
QuintilesIMS
Baxter
Federal Trade Commission
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.